Literature DB >> 8064071

Reduced secretion of IgA to skin surface of patients with atopic dermatitis.

S Imayama1, Y Shimozono, M Hoashi, S Yasumoto, S Ohta, K Yoneyama, Y Hori.   

Abstract

To investigate whether the secretory form of immunoglobulin A (sIgA) was reduced on the skin surface in atopic dermatitis, the amount of sIgA present in sweat was measured in 40 patients with atopic dermatitis and in 50 healthy volunteers by attaching a cellulose membrane disk (10 x 10 mm) to the inner aspect of the upper arm skin for 24 hours. The secretory form of IgA, which was absorbed to the membrane and accumulated during the period of application, was revealed as dots by an enzyme immunoassay in which antibodies for IgA and for the secretory component were used. The density and number of dots (per mm2/day), which corresponded to the openings of eccrine excretory ducts, were determined with a densitometer. The mean amount of sIgA secreted by those patients was 3.86 +/- 0.71 pg/mm2/day (range, 0 to 21.17 pg/mm2/day), whereas that of the control subjects was significantly higher (p < 0.001), 16.79 +/- 2.80 pg/mm2/day (range, 0.79 to 133.77 pg/mm2/day). This may be related to the high incidence of bacterial and viral skin infections seen in patients with atopic dermatitis, and in addition, to the development of eczematous lesions through a defect in ridding the skin of allergens and/or microorganisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064071     DOI: 10.1016/0091-6749(94)90040-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Increased number of IgE positive Langerhans cells in the conjunctiva of patients with atopic dermatitis.

Authors:  A Yoshida; S Imayama; S Sugai; Y Kawano; T Ishibashi
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis.

Authors:  Y Ohnishi; N Okino; M Ito; S Imayama
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

3.  Dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation.

Authors:  Saki Matsui; Hiroyuki Murota; Aya Takahashi; Lingli Yang; Jeong-Beom Lee; Kouta Omiya; Masato Ohmi; Junichi Kikuta; Masaru Ishii; Ichiro Katayama
Journal:  J Invest Dermatol       Date:  2013-07-30       Impact factor: 8.551

4.  Evaluation of total and allergen-specific secretory IgA in tears of allergic conjunctival disease patients.

Authors:  Noriko Inada; Jun Shoji; Mai Hoshino; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

Review 5.  The role of microorganisms in atopic dermatitis.

Authors:  Barbara S Baker
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

6.  Effects of High-Intensity Endurance Exercise on Epidermal Barriers against Microbial Invasion.

Authors:  Nobuhiko Eda; Kazuhiro Shimizu; Satomi Suzuki; Eunjae Lee; Takao Akama
Journal:  J Sports Sci Med       Date:  2013-03-01       Impact factor: 2.988

Review 7.  Tissues: the unexplored frontier of antibody mediated immunity.

Authors:  Nicholas E Webb; Biana Bernshtein; Galit Alter
Journal:  Curr Opin Virol       Date:  2021-02-10       Impact factor: 7.090

8.  Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man.

Authors:  Vassiliki Bekou; Amanda Büchau; Michael J Flaig; Thomas Ruzicka; Michael Hogardt
Journal:  BMC Dermatol       Date:  2011-01-26

9.  Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment.

Authors:  Emi Ono; Hiroyuki Murota; Yuki Mori; Yoshichika Yoshioka; Yuko Nomura; Takichi Munetsugu; Hiroo Yokozeki; Ichiro Katayama
Journal:  PLoS One       Date:  2018-04-20       Impact factor: 3.240

Review 10.  Atopic Dermatitis: Identification and Management of Complicating Factors.

Authors:  Risa Tamagawa-Mineoka; Norito Katoh
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.